+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07277270

Evaluation of GSK5764227 Combined With Standard Treatments for Advanced Solid Tumors Including Colorectal and Prostate Cancer

Led by GlaxoSmithKline · Updated on 2026-09-25

83

Participants Needed

22

Research Sites

115 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new medicine called GSK5764227 designed to deliver a toxin directly to cancer cells to destroy them while sparing healthy cells. This study tests the combination of GSK5764227 with standard treatments for advanced solid tumors, including metastatic colorectal cancer and metastatic castration-resistant prostate cancer. The purpose is to assess the safety, how the body processes the drug, immune responses triggered, and its ability to shrink or control cancer. Participants receive GSK5764227 along with other drugs such as bevacizumab, fluorouracil, leucovorin, or enzalutamide depending on the cancer type. The study is non-randomized and conducted in a sequential model with different cohorts for the cancer types. Treatment and assessments occur over up to approximately 31 weeks for safety and up to 112 weeks for extended monitoring of drug levels, immune response, and cancer control measures. During the study, participants will be monitored for adverse events, dose tolerability, and changes in vital signs, laboratory tests, and cardiac function. Researchers will also measure drug concentration in plasma, immune antibody formation, and evaluate cancer response rates and progression-free survival. The total participation may last several years with ongoing evaluations, and all activities are conducted under medical supervision to track safety and clinical activity.

CONDITIONS

Brief Title

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Research Team

U

US GSK Clinical Trials Call Center

E

EU GSK Clinical Trials Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here